Skip to main content
. 2019 May 1;36(3):243–250. doi: 10.36141/svdld.v36i3.8219

Table 2.

Clinical characteristics of vasculitis group

Variables Number (n=126) Percent
Types of vasculitis
Polymyalgia rheumatica/giant cell arteritis 28 22.2
Granulomatosis with polyangiitis 26 20.6
Cutaneous small-vessel vasculitis 15 11.9
Undifferentiated vasculitis 15 11.9
Takayasu arteritis 12 9.5
Polyarteritis nodosa 10 7.9
Eosinophilic granulomatosis with polyangiitis 6 4.8
Hypocomplementemic urticarial vasculitis 5 4.0
IgA vasculitis 4 3.2
Microscopic Polyangiitis 4 3.2
Central nervous system vasculitis 1 0.8
Disease duration (months) 37.72±18.1 -
Clinical manifestations
General symptoms 74 58.7
Cutaneous and mucous membranes involvement 57 45.2
Ophthalmic involvement 10 7.9
Ears, nose and throat involvement 26 20.6
Pulmonary involvement 25 19.8
Cardiovascular system involvement 19 15.1
Abdominal involvement 6 4.8
Renal involvement 40 31.7
Nervous System involvement 41 32.5
BVAS 10.6 (1-36) -

BVAS: Birmingham Vasculitis Activity Score.

Data were displayed as numbers (percentages), means ± SD or median (Min-Max), as appropriate